Impact of clinical pharmacy services on stress ulcer prophylaxis prescribing and related cost in patients with renal insufficiency
| Autor: | Maryam Mousavi, Simin Dashti-Khavidaki, Hossein Khalili, Amir Farshchi, Mansoor Gatmiri |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Adult
Male Nephrology Peptic Ulcer medicine.medical_specialty Gastrointestinal bleeding Adolescent Population Pharmaceutical Science Inappropriate Prescribing Pharmacy Pharmacists Young Adult Professional Role Internal medicine Health care medicine Humans In patient Practice Patterns Physicians' Renal Insufficiency Chronic Intensive care medicine education Aged Aged 80 and over Patient Care Team education.field_of_study business.industry Health Policy Stress ulcer Public Health Environmental and Occupational Health Health Care Costs Middle Aged Anti-Ulcer Agents medicine.disease Clinical pharmacy Practice Guidelines as Topic Female Pharmacy Service Hospital business Kidney disease |
| Zdroj: | International Journal of Pharmacy Practice. 21:263-269 |
| ISSN: | 2042-7174 0961-7671 |
| DOI: | 10.1111/ijpp.12005 |
| Popis: | Objectives Compared to the general population, chronic kidney disease patients are more vulnerable to gastrointestinal haemorrhage and its morbidity and mortality. Due to the fear of gastrointestinal bleeding consequences in these patients on the one hand, and the perception of general safety of acid suppressive medications on the other hand, inappropriate stress ulcer prophylaxis (SUP) seems to be encountered in nephrology wards. The objectives of this study were to evaluate appropriateness of acid suppression therapy in kidney disease patients and to assess the role of clinical pharmacists to decrease inappropriate SUP prescribing and related costs for these patients. Methods All inpatients at nephrology wards of a teaching hospital were assessed regarding appropriate SUP prescribing during a 6-month pre-intervention phase of the study without any clinical pharmacists' involvement in patients' management. Thereafter, during a 6-month post-intervention phase clinical pharmacists provided local SUP protocol and educational classes for physicians regarding appropriate SUP prescribing and participated actively in the patient-care team. Main findings The results showed significant relative reduction in inappropriate SUP prescribing and related cost in patients with renal insufficiency by about 44% and 67% respectively. Conclusion This study showed that implementing institutional guidelines, and active involvement of clinical pharmacists in the nephrology healthcare team, could reduce inappropriate SUP prescribing and related costs for these patients. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text